If PTAB Backs Berkeley IP Holders' New Patent Claims, CRISPR Licensing Could Be Simplified

 
• By Joseph Haas
  
INTELLECTUAL PROPERTY Business team hands at work with financial reports and a laptop - Image
IP rights to CRISPR-Cas9 technology again are being investigated by the USPTO
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business